Home > Products > EGFR & MET
> Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Tandem Diabody)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-154)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Pancreatic cancer; Head and neck cancer; Non-small cell lung cancer (NSCLC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Tandem Diabody) (T-BSDB-154). Click the button below to contact us or submit your feedback about this product.